I agree that this site is using cookies. You can find further informations here.
X
Shitara, Kohei
401  results:
Search for persons X
?
1

Clinical practice guidelines for esophagogastric junction c..:

Kitagawa, Yuko ; Matsuda, Satoru ; Gotoda, Takuji...
Gastric Cancer.  27 (2024)  3 - p. 401-425 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Efficacy and Safety of Trifluridine/Tipiracil-Containing Co..:

Shitara, Kohei ; Falcone, Alfred ; Fakih, Marwan G...
The Oncologist.  29 (2024)  5 - p. e601-e615 , 2024
Link: https://doi.org/10.1093/..
 
?
3

Whole‐transcriptome sequencing in advanced gastric or gastr..:

Hashimoto, Tadayoshi ; Nakamura, Yoshiaki ; Mishima, Saori...
Cancer Science.  115 (2024)  5 - p. 1622-1633 , 2024
Link: https://doi.org/10.1111/..
 
?
4

The Prognostic Nutritional Index in patients with microsate..:

Ghelardi, Filippo ; Fucà, Giovanni ; Cavalli, Chiara...
Digestive and Liver Disease.  , 2024
Link: https://doi.org/10.1016/..
 
?
5

Claudin 18.2 as a novel therapeutic target:

Nakayama, Izuma ; Qi, Changsong ; Chen, Yang...
Nature Reviews Clinical Oncology.  21 (2024)  5 - p. 354-369 , 2024
Link: https://doi.org/10.1038/..
 
?
6

Potential Efficacy of Shiunko for Anti-Epidermal Growth Fac..:

Okunaka, Mashiro ; Kotani, Daisuke ; Mishima, Saori...
Integrative Cancer Therapies.  23 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
7

Baseline ctDNA gene alterations as a biomarker of survival ..:

Shitara, Kohei ; Muro, Kei ; Watanabe, Jun...
Nature Medicine.  30 (2024)  3 - p. 730-739 , 2024
Link: https://doi.org/10.1038/..
 
?
8

A meta-analysis of efficacy and safety data from head-to-he..:

Yoshino, Takayuki ; Hooda, Naushin ; Younan, Diana...
European Journal of Cancer.  202 (2024)  - p. 113975 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Monoclonal antibodies that target fibroblast growth factor ..:

Katoh, Masuko ; Nakayama, Izuma ; Wainberg, Zev A..
Clinical and Translational Medicine.  14 (2024)  6 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
10

Multiomic molecular characterization of the response to com..:

Takei, Shogo ; Tanaka, Yosuke ; Lin, Yi-Tzu...
Journal for ImmunoTherapy of Cancer.  12 (2024)  2 - p. e008210 , 2024
Link: https://doi.org/10.1136/..
 
?
11

Zolbetuximab plus chemotherapy for locally advanced unresec..:

Shitara, Kohei ; Shah, Manish A. ; Lordick, Florian...
Future Oncology.  , 2024
Link: https://doi.org/10.1080/..
 
?
12

Zolbetuximab for Claudin18.2-positive gastric or gastroesop..:

Kubota, Yohei ; Shitara, Kohei
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
13

Trastuzumab deruxtecan in HER2-positive advanced gastric ca..:

Shitara, Kohei ; Bang, Yung-Jue ; Iwasa, Satoru...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
14

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in..:

Shitara, Kohei ; Rha, Sun Young ; Wyrwicz, Lucjan S...
The Lancet Oncology.  25 (2024)  2 - p. 212-224 , 2024
Link: https://doi.org/10.1016/..
 
?
15

Safety profile of pembrolizumab monotherapy based on an agg..:

Brahmer, Julie R. ; Long, Georgina V. ; Hamid, Omid...
European Journal of Cancer.  199 (2024)  - p. 113530 , 2024
Link: https://doi.org/10.1016/..
 
1-15